Increase in serum prolactin levels as a potential biomarker in Crohn’s disease: a prospective cohort study
Elevated serum PRL may serve as a supplementary biomarker reflecting immune dysregulation and disease activity in CD, particularly in this cohort enriched with severe, perianal-dominant disease. Its role in evaluating therapeutic effectiveness warrants further investigation.
Authors
- L. Qiao
- Bolin Yang
- Xinyi Tang
- Minmin Xu
- Mengjie Lu
Institutions
- Nanjing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-19
- DOI
- https://doi.org/10.3389/fmed.2026.1737904
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province